Abstract: Embodiments relate to compositions comprising a prochlorperazine compound and a nasal carrier, including methods for formulating such compositions for pharmaceutical applications, for example, for treating or reducing the incidence of migraine headaches. Additional embodiments relate to articles comprising a prochlorperazine compound and a nasal carrier, including use of such articles as nasal drops or nasal sprays. Further embodiments relate to methods for using such articles, for example, for treating or reducing the incidence of migraines.
Abstract: The present invention is directed towards methods for treating non-alcoholic fatty liver disease (NAFLD) in a patient and determining prognosis of NAFLD in a patient.
Type:
Grant
Filed:
August 25, 2016
Date of Patent:
March 17, 2020
Assignee:
Roseman University of Health Sciences
Inventors:
Thuc T. Le, Yasuyo Urasaki, Ronald R. Fiscus
Abstract: The present invention is directed towards methods for treating non-alcoholic fatty liver disease (NAFLD) in a patient and determining prognosis of NAFLD in a patient.
Type:
Application
Filed:
August 25, 2016
Publication date:
September 13, 2018
Applicant:
Roseman University of Health Sciences
Inventors:
Thuc T. LE, Yasuyo URASAKI, Ronald R. FISCUS